Mandate

Vinge has advised Xspray Pharma in connection with share issue

Vinge has advised Xspray Pharma, a pharmaceutical company with several product candidates in clinical development listed on Nasdaq Stockholm, in connection with a share issue whereby the company raises proceeds of SEK 100 million.

Vinge’s team consisted of Dain Hård Nevonen, Joel Magnusson and Gabriel Chabo.

Related

Vinge has advised management of atNorth in connection with the sale of atNorth to CPP Investments and Equinix

Vinge has advised management of atNorth on the sale of atNorth to Canada Pension Plan Investment Board (CPP Investments) and Equinix (EMEA) Management, Inc. from Partners Group and the minority shareholders.
March 02, 2026

Vinge advises Smart Eye on acquisition of Sightic Analytics

Smart Eye has entered into an agreement to acquire all shares in Sightic Analytics for a fixed purchase price of SEK 60.5 million, to be paid with newly issued shares in Smart Eye, and an additional purchase price of up to SEK 50 million, conditional upon certain financial and operational targets being met.
February 24, 2026

Vinge advises Axcel and Accru Partners in connection with the acquisitions of Baker Tilly Uppsala AB and Baker Tilly Guide AB

Vinge has advised Axcel VII and Accru Partners in connection with the acquisitions of Baker Tilly Uppsala AB and Baker Tilly Guide AB.
February 22, 2026